Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/101620

In Collections

This item can be found in the following collections:

Smolen, J.S.; Vollenhoven, R. van; Kavanaugh, A.; Strand, V.; Vencovsky, J.; Schiff, M.; ... ; Heijde, D. van der (2015)

Certolizumab pegol plus methotrexate 5-year results from the rheumatoid arthritis prevention of structural damage (RAPID) 2 randomized controlled trial and long-term extension in rheumatoid arthritis patients

Article / Letter to editor
All authors
Smolen, J.S.; Vollenhoven, R. van; Kavanaugh, A.; Strand, V.; Vencovsky, J.; Schiff, M.; Landewe, R.; Haraoui, B.; Arendt, C.; Mountian, I.; Carter, D.; Heijde, D. van der
Date
2015-09-10
Volume
17
DOI
doi:10.1186/s13075-015-0767-2